Clinical trial
Resting State MRI Connectivity in Acute Ischemic Stroke: Serotonin Selective Reuptake Inhibitor (SSRI) in Enhancing Motor Recovery: a Placebo Controlled Study
NCT02767999 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resting State MRI Connectivity in Acute Ischemic Stroke: Serotonin Selective Reuptake Inhibitor (SSRI) in Enhancing Motor Recovery: a Placebo Controlled Study
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 27, 2017
- Completion date
- January 31, 2022
- Enrollment
- 25 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.